Your browser doesn't support javascript.
loading
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Schmid, Peter; Rugo, Hope S; Adams, Sylvia; Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Diéras, Véronique; Henschel, Volkmar; Molinero, Luciana; Chui, Stephen Y; Maiya, Vidya; Husain, Amreen; Winer, Eric P; Loi, Sherene; Emens, Leisha A.
Afiliação
  • Schmid P; Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: p.schmid@qmul.ac.uk.
  • Rugo HS; University of California San Francisco Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
  • Adams S; Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
  • Schneeweiss A; National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Barrios CH; Centro de Pesquisa Clínica, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Grupo Oncoclínicas, Porto Alegre, Brazil.
  • Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Diéras V; Department of Medical Oncology, Institut Curie, Paris, France; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Henschel V; F Hoffmann-La Roche, Basel, Switzerland.
  • Molinero L; Genentech, South San Francisco, CA, USA.
  • Chui SY; Genentech, South San Francisco, CA, USA.
  • Maiya V; Genentech, South San Francisco, CA, USA.
  • Husain A; F Hoffmann-La Roche, Basel, Switzerland.
  • Winer EP; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
  • Emens LA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.
Lancet Oncol ; 21(1): 44-59, 2020 01.
Article em En | MEDLINE | ID: mdl-31786121
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article